Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
16 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Tenet Healthcare Corporation New’s names, not what it holds today.
Patents granted
16
16 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
1
since 2001, to Dec 31, 2025
Names they are printed under
3
a subsidiary
By yearGrantedApplications published
'93'94'95'96'97'98'13'15'23
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name3 counted
Digestive Care Inc. a subsidiary
US, as the owner printed on each patent
0 publishedHOLY CROSS HOSPITAL, INC. a subsidiary
US, as the owner printed on each patent
0 publishedHoly Cross Hospital, Inc. a subsidiary
named as the applicant on its applications, in US
1 publishedNames not counted (3)
APN
Most of its patents print CA; this name counts in US. 0 granted and 1 published under it are not counted.
APN
Most of its patents print CA; this name counts in US. 1 granted and 0 published under it are not counted.
CEC, LLC
Most of its patents print PT; this name counts in US. 1 granted and 0 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 29, 2015 | 9,220,813 | Cell therapy for limiting overzealous inflammatory reactions in tissue healing | Medical technology | HOLY CROSS HOSPITAL, INC. |
| Dec 10, 2013 | 8,603,463 | Recovery of tissue function following administration of B cells to injured tissue | Pharmaceuticals | HOLY CROSS HOSPITAL, INC. |
| May 12, 1998 | 5,750,104 | High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith | Pharmaceuticals | Digestive Care Inc. |
| Mar 25, 1997 | 5,614,223 | Intraoral medicament-releasing device | Pharmaceuticals | Digestive Care Inc. |
| Nov 26, 1996 | 5,578,304 | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof | Pharmaceuticals | Digestive Care Inc. |
| Oct 24, 1995 | 5,460,812 | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof | Pharmaceuticals | Digestive Care Inc. |
| Jul 18, 1995 | 5,433,952 | Intraoral medicament-releasing device | Pharmaceuticals | Digestive Care Inc. |
| May 16, 1995 | 5,415,872 | Compositions of gastric acid-resistant microspheres containing salts of bile acids | Pharmaceuticals | Digestive Care Inc. |
| Apr 11, 1995 | 5,405,621 | Compositions of gastric acid-resistant microspheres containing buffered bile acids | Pharmaceuticals | Digestive Care Inc. |
| Oct 4, 1994 | 5,352,682 | Compositions containing salts of bile acid-aminosalicylate conjugates | Pharmaceuticals | Digestive Care Inc. |
Newest applications publishedan application is a clue, never a plan
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.